FAMPART: Pilot Trial of Family Partner - a Child Maltreatment Prevention Intervention

Sponsor
Oslo Metropolitan University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04957394
Collaborator
SOS Children's Villages, Norway (Other), Øvre Eiker municipality (Other), Lillehammer municipality (Other)
240
3
2
60
80
1.3

Study Details

Study Description

Brief Summary

Prior to this pilot study, it is unclear whether comparing a manualized version of the Family Partner Model to standard practice in the Child Welfare Services would be feasible. Results will inform whether and how to design a fully powered randomized controlled trial to test the effects of a manualized version of the Family Partner Model on child maltreatment. The specific results of the pilot study will inform 1) randomization procedures, 2) data sources to be used, 3) sample size calculations, and 4) adaptations to the design and measures for a fully powered randomized controlled trial.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Family Partner
N/A

Detailed Description

The objective is to assess the adaptability and acceptability of the Family Partner Intervention, and the feasibility of a future randomised controlled trial. Our specific research questions are:

  1. What is the adaptability, acceptability, and feasibility of the Family Partner intervention in a Norwegian municipal context?

  2. What are the experiences and possible outcomes of the Family Partner intervention?

  3. Is the trial design feasible for an RCT expansion?

The investigators will pilot a parallel randomized trial (RCT), allocated to two groups (treatment and control). Families that fit to the target group, will be invited to take part in the study. Each family which fit the inclusion criteria and consent to participate will be randomized with a 1:1 allocation to experimental and control groups. Each Family Partner can serve 5 families at a time, and the Family Partner will serve families from 6-18 months. As families complete the programme, new families will be recruited. Hence, the recruitment and randomization will be an ongoing process. Any changes to methods after pilot trial commencement will be reported along with study results.

In a future RCT, the objective is to evaluate the effectiveness of the Family Partner Intervention, i.e. whether introducing the intervention would improve the outcome of existing Child Welfare Services. Hence, the trial is a superiority trial, in which the Family Partner Intervention is hypothesized to be superior to existing service provision. The trial is designed according to an intention-to-treat principle, where all consented participants are included in the analyses, independent of their adherence to intervention.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
240 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Family Partner -Co-development, Implementation and Evaluation of a Child Maltreatment Prevention Intervention
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental (Family Partner)

The treatment group will receive six hours follow-up and support weekly. The service will be provided by a dedicated Family Partner.

Behavioral: Family Partner
The Family Partner intervention is based on well-known elements for preventing child abuse and neglect, such as 1) high intensity intervention with home visitations, 2) coordination of services, 3) an ecological perspective, 4) parental guidance, and 5) an emphasis on a therapeutic relationship with parents to create trust, change and agency. Family Partners must have relevant professional background and education, such as social work, child welfare services and other health/welfare occupations. They must have a personal attitude for relation-based service delivery in a home-setting, a long work experience and in-depth knowledge of municipal welfare services. Each practitioner will follow five families. The estimated duration of the intervention is 12 months, but might go over longer stretches of time if it is considered beneficial for the families. The minimum duration of the intervention is 3 months.

No Intervention: Control group

The control group will receive defult support from the child welfare services. The service will be "business as usual", provided by the local staff at the child welfare services.

Outcome Measures

Primary Outcome Measures

  1. Acceptability [Acceptability at 12 months]

    Intervention Rating Profile (IRP-15)

Secondary Outcome Measures

  1. Relationship between the Family Partner and the parents [Change from Baseline WAI at 3, 6, 9, 12, 15 and 18 months]

    The Working Alliance Inventory (WAI)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • parents are 18 years or older, and

  • children are under 18 years, and

  • families with complex challenges who are already involved in the Child Welfare Services, and

  • children live under potentially harmful circumstances, and

  • parents struggle in several areas, e.g. employment, poverty, drug misuse, mental health

Exclusion criteria:

None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Øvre Eiker kommune Drammen Norway
2 Larvik kommune Larvik Norway
3 Lillehammer kommune Lillehammer Norway

Sponsors and Collaborators

  • Oslo Metropolitan University
  • SOS Children's Villages, Norway
  • Øvre Eiker municipality
  • Lillehammer municipality

Investigators

  • Principal Investigator: Anne Grete G Tøge, phd, associate professor
  • Principal Investigator: Eirin G Pedersen, phd, Senior Researcher

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Oslo Metropolitan University
ClinicalTrials.gov Identifier:
NCT04957394
Other Study ID Numbers:
  • 804402
First Posted:
Jul 12, 2021
Last Update Posted:
Jan 27, 2022
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 27, 2022